“Armed with positive results from testing and field trials by veterinarians and hoof care specialists of our recently developed hoof and leg products for animals, it became increasingly apparent to us that our technology could play a pivotal role in the human wound care field,” stated BioLargo’s president, Dennis Calvert. “With the need for wound care products without microbial resistance so great, the commitment to this vertical market became the next logical and necessary step.”
With disease resulting from antibiotic resistant bacteria such as c.diff and staph on the rise and ever more making headlines, the industry has a great need for a product with no known microbial resistance. Advanced wound care products include wound washes, wound gels, and wound dressings, among others. As reported in the Wall Street Journal, current research projects that the globaladvanced wound care market will rise to nearly $21 billion in 2015. Significant areas of development are within the areas of antimicrobials (including iodine), hydrogels and other dressings.

University of Alberta Department of Engineering, has begun.

BioLargo® announced the introduction of its free iodine liquid wash and “hydrogel” products branded Nature’s Best Solution®.

The wash and hydrogel have both consumer and industrial strength applications for use as a general wash and odor control. The company generated its first commercial sale and has begun to deliver the products to prospective industrial customers for trials.

They deliver the market’s highest dose of free iodine in solution while retaining its non- staining, G.R.A.S. (Generally Regarded as Safe) designation, as well as its non-toxic and green attributes. Slated to become a staple in BioLargo’s product menu, the stabilized formula provides a platform for new products because additional ingredients can easily be added to create a host of new applications. BioLargo will continue to validate the base product and secure commercial opportunities while it seeks to establish a distribution channel.

BioLargo further announced it contracted with a “dairy industry” distributor located in Tulare California to begin distributing its new and existing iodine based products. The new distributor, Green Alpha Solutions, LLC, is led by two regional dairy industry experts who bring innovative technology based solutions to the regional dairy marketplace. BioLargo will continue separate discussions with licensing and manufacturing partners to advance new product designs to best serve this highly specialized market.

On the consumer front, BioLargo announced it had developed a family of consumer products branded DeodorAllTM for household stain and odor removal and spill clean-up. The Home Shopping Group will produce, manage and broadcast a series of direct response television campaigns to introduce the product to the marketplace in the coming months. BioLargo will supply products to the project on a wholesale price basis while maintaining approval rights for content that is created.

BioLargo further announced it has established a relationship with Spill Experts, Inc., a company that specializes in spill clean-up products with more than 20 years in the industry.

Spill Experts recently tested BioLargo’s technology in multiple client trials which proved highly effective for use in cleaning up human body fluids and controlling odor with a target market focused on public buildings and public transportation like buses, trains, subways and the like. As a result of the success of the trials, BioLargo has agreed to supply Spill Experts absorbent materials treated with its BioLargo® technology, in bulk, in order for Spill Experts to combine the materials with its own absorbents and sell a Spill Experts branded product in the US and Canada. The mark, “BioLargo® Technology Inside,” will be displayed on the front of the package. Spill Experts placed its first order and the new products are being marketing by Spill Experts.

BioLargo continues to advance its work in animal and human health areas. It successfully concluded its first phase testing to verify that its product formulas are non-cytotoxic and effective as a disinfectant against of host of pathogens commonly found in a healthcare setting. Its animal health products are being tested in a host of non-commercial settings by leading veterinarians across the nation.

“In many ways, we have only shown the world the ‘tip of the iceberg’ of the expansive opportunities for our commercial success,” commented Dennis Calvert, President and CEO. “Our product development work with Central Garden and Pet has led to the creation of a number of complete product designs which we believe are ready for market, and a long list of potential future products for the pet industry. Similarly, in each industry in which we focus, we have products that represent a starting point and at the same time, we face the exciting opportunity to develop a complete line of products to serve those industries. The core technology is well established and with the addition of our world-class team members over the past year, it is now a great time for BioLargo to refine, focus and execute to help solve serious problems that face industry and our world.”

The Canadian Oil Sands are the second largest deposit of oil in the world. Extracting oil from the Oil Sands creates high volumes of contaminated water (between 2 and 4.5 barrels of water to produce one barrel of synthetic crude oil), currently discharged in “tailings” ponds, sometimes for years, to separate the solids from the liquids for eventual recycling or safe discharge into the environment. With Canadian oil production estimated to increase from 1.9 million to over 6 million barrels of oil a day over the next 20 years, the released water from oil sands operations is estimated to reach one billion cubic meters in the Athabasca oils sands region by 2025. An innovative solution that can reduce the water treatment time, and thus the overall footprint and environmental impact of the tailings ponds, is required for Canada to meet its production goals. It is widely believed that the future of oil sands exploration, its social and economic contribution as the second largest oil reserve in the world, and its contribution to the public good of both Canada and the Unites States, hinges on industry’s ability to manage the wastewater in tailings ponds.

In addition to BioLargo, the new Research Chair is sponsored by the Natural Sciences and Engineering Research Council of Canada (NSERC), as well as a number of related researchers and industry stakeholders that include world-leading oil companies and the regional water district for the Province of Alberta.

“We are honored to be part of this important work for Canada and the United States,” stated BioLargo President and CEO Dennis Calvert. Ken Code, the company’s Chief Technical Officer added, “The Chair objectives are perfectly aligned with our goal to improve the quality of life for people worldwide, while we work to protect the environment, and produce positive economic results for our customers, partners, and stockholders. We look forward to serving with the other founders.”

About University of Alberta’s Department of Civil and Environmental Engineering and Professor Gamal-El Din

Dr. Mohamed Gamal El-Din, head of the new Research Chair, is a Professor with the Department of Civil and Environmental Engineering at the University of Alberta. His expertise and research in the area of water and wastewater treatment places him amongst the top scientists in the world. He has been published in peer-reviewed journal a substantial number of times, and written and presented extensively on these subjects. In 2005, he received the Petro-Canada Young Innovator Award and was the recipient of the Alberta Ingenuity New Faculty Grant in Alberta. In 2008, he was awarded one of the 2008 NSERC Accelerator Discovery Grants. Dr. Gamal El-Din has been acting as an editorial board member for the Ozone Science & Engineering Journal and has been also acting as a reviewer for many referred journals. He is a current member of the Canadian Society for Civil Engineering (CSCE), American Water Works Association (AWWA), International Water Association (IWA), International Ozone Association (IOA), International UV Association (IUVA), Water Environment Federation (WEF), Association of Professional Engineers, Geologists, and Geophysicists of Alberta (APEGGA), and Egyptian Syndicate of Civil Engineers.

About BioLargo, Inc.

BioLargo’s business strategy is to harness and deliver Nature’s Best Solution® — free-iodine — in a safe, efficient, environmentally sensitive and cost-effective manner. Its proprietary technology works by combining micro-nutrient salts with liquid from any source to deliver free-iodine on demand, in controlled dosages, in order to balance efficacy of performance with concerns about toxicity. The technology has potential commercial applications within global industries, including but not limited to oil and gas, animal health, beach and soil environmental uses, consumer products, agriculture, food processing, medical, and water. It features solutions for odor & moisture control, disinfection and contaminated water treatment. The company’s goal is to improve the quality of life for people worldwide, while it protects the environment, and produces positive economic results for our customers, partners, and shareholders. Its website is www.BioLargo.com. Its Odor-No-More® product was awarded two Editor’s Choice Awards, including a “Product of the Year” award, by the Horse Journal, a top industry publication, as well as a Best New Product SuperZoo Award, and are sold by BioLargo’s wholly owned subsidiary, Odor-No-More, Inc. (www.OdorNoMore.com). BioLargo also owns a 50% interest in the Isan System, already commercialized in Australia, which was honored with a Top 50 Water Company for the 21st Century award by the Artemis Project. In early 2011, the company signed an exclusive license agreement for use in pet products with industry leader Central Garden and Pet.

Safe Harbor Statement

The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo’s current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo’s Annual Report on Form 10-K for the year ended December 31, 2010.

About BioLargo, Inc.

BioLargo’s business strategy is to harness and deliver Nature’s Best Solution™ — free-iodine — in a safe, efficient, environmentally sensitive and cost-effective manner. BioLargo’s proprietary technology works by combining micro-nutrient salts with liquid from any source to deliver free-iodine on demand, in controlled dosages, in order to balance efficacy of performance with concerns about toxicity. BioLargo’s technology has potential commercial applications within global industries, including but not limited to oil and gas, animal health, beach and soil environmental uses, consumer products, agriculture, food processing, medical, and water. It features solutions for odor & moisture control, disinfection and contaminated water treatment. The company’s website is www.BioLargo.com. In 2010, Odor-No-More was awarded two Editor’s Choice Awards, including a “Product of the Year” award, by the Horse Journal, a top industry award for excellence, and are sold by BioLargo’s wholly owned subsidiary, Odor-No-More, Inc. (www.OdorNoMore.com). In early 2011, the company signed an exclusive license agreement for use in pet products with industry leader Central Garden and Pet.

Safe Harbor Statement

The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo’s current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo’s Annual Report on Form 10-K for the year ended December 31, 2010.

John Runyan has spent his career in the food industry. He began as a stock boy at age 12, and ultimately served the Fleming Companies for 38 years, his last 10 as a Senior Executive Officer in its corporate headquarters where he was Group President of Price Impact Retail Stores with annual sales of over $3 billion. He retired from Fleming in 2001, and established JSR&R Company executive advising, with a primary emphasis in the United States and international food business. His clients have included Coca Cola, Food 4 Less Price Impact Stores, IGA, Inc., Golden State Foods, and Bozzuto. In 2005, he joined Associated Grocers in Seattle, Washington as President and CEO, overseeing its purchase in 2007 by Unified Grocers, at which time he became, and still serves as, Executive Advisor to its President and CEO. Mr. Runyan currently serves on the Board of Directors of Western Association of Food Chains, Retailer Owned Food Distributors of America, and Nietech Company of Santa Rosa, California. Additionally, Mr. Runyan served 8 years as a board member of the City of Hope’s Northern California Food Industry Circle, which included two terms and President, was recognized with the City of Hope “Spirit of Life” award. He was the first wholesale executive to be voted “Man of the Year” by Food People Publication. He is a graduate of Washburn University, which recognized his business accomplishments in 2007 as the honoree from the School of Business “Alumni Fellow Award.”

“John brings a wealth of experience and knowledge to compliment and assist our team. He is a man of integrity that has a proven track record of success as well as exceptional leadership and executive management skills. John has relationships that span the retail, wholesale, food, and industry related suppliers as well as consumer products industries. We are fortunate to have him associated with BioLargo,” stated BioLargo President and CEO, Dennis P. Calvert.

About BioLargo, Inc.

BioLargo’s business strategy is to harness and deliver Nature’s Best Solution™ — free-iodine — in a safe, efficient, environmentally sensitive and cost-effective manner. BioLargo’s proprietary technology works by combining micro-nutrient salts with liquid from any source to deliver free-iodine on demand, in controlled dosages, in order to balance efficacy of performance with concerns about toxicity. BioLargo’s technology has potential commercial applications within global industries, including but not limited to oil and gas, animal health, beach and soil environmental uses, consumer products, agriculture, food processing, medical, and water. It features solutions for odor & moisture control, disinfection and contaminated water treatment. The company’s website is www.BioLargo.com. In 2010, Odor-No-More was awarded two Editor’s Choice Awards, including a “Product of the Year” award, by the Horse Journal, a top industry award for excellence and are sold by BioLargo’s wholly owned subsidiary, Odor-No-More, Inc. (www.OdorNoMore.com). In early 2011, the company signed an exclusive license agreement for use in pet products with industry leader Central Garden and Pet.

Safe Harbor Statement

The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo’s current and future filings with the Securities and Exchange Commission, including those set forth in the BioLargo’s Annual Report on Form 10-K for the year ended December 31, 2010.

About BioLargo, Inc.

BioLargo’s business strategy is to harness and deliver Nature’s Best Solution™ — free-iodine — in a safe, efficient, environmentally sensitive and cost-effective manner. BioLargo’s proprietary technology works by combining micro-nutrient salts with liquid from any source to deliver free-iodine on demand, in controlled dosages, in order to balance efficacy of performance with concerns about toxicity. BioLargo’s technology has potential commercial applications within global industries, including but not limited to oil and gas, animal health, beach and soil environmental uses, consumer products, agriculture, food processing, medical, and water. It features solutions for odor & moisture control, disinfection and contaminated water treatment. The company’s website is www.BioLargo.com. In 2010, Odor-No-More was awarded two Editor’s Choice Awards, including a “Product of the Year” award, by the Horse Journal, a top industry award for excellence and are sold by BioLargo’s wholly owned subsidiary, Odor-No-More, Inc. (www.OdorNoMore.com). In early 2011, the company signed an exclusive license agreement for use in pet products with industry leader Central Garden and Pet.

Safe Harbor Statement

The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo’s current and future filings with the Securities and Exchange Commission, including those set forth in the BioLargo’s Annual Report on Form 10-K for the year ended December 31, 2010.

“BioLargo has am environmentally sensitive answer to many of the problems associated with the controversial drilling technique known as hydraulic fracturing, or ‘fracking’, as well as other contaminated water treatment issues within various industries. Between the oil sands and the fracking waters, BioLargo has an important role to play in helping improve safety and helping industry continue to maintain best practices to protect the environment. Our technology helps address the most important water management issues that are pivotal in oil sands and natural gas production which are believed to be the fastest growing and likely the most important segments of the oil and gas industry because they are widely believed to be the key to developing energy self-sufficiency for North America,” stated BioLargo’s president, Dennis Calvert. “Dr. Bickerstaff will work closely with Kenneth Reay Code, our inventor and Chief Technology Officer, and our Senior Advisor Vikram Rao, former Chief Technology Officer of Halliburton and Executive Director of the Research Triangle Energy Consortium, to advance our claims and commercial plan.”

About BioLargo, Inc.

BioLargo’s business strategy is to harness and deliver Nature’s Best Solution™ — free-iodine — in a safe, efficient, environmentally sensitive and cost-effective manner. BioLargo’s proprietary technology works by combining micro-nutrient salts with liquid from any source to deliver free-iodine on demand, in controlled dosages, in order to balance efficacy of performance with concerns about toxicity. BioLargo’s technology has potential commercial applications within global industries, including but not limited to oil and gas, animal health, beach and soil environmental uses, consumer products, agriculture, food processing, medical, and water. It features solutions for odor and moisture control, disinfection and contaminated water treatment. The company’s website is www.BioLargo.com. In 2010, Odor-No-More was awarded two Editor’s Choice Awards, including a “Product of the Year” award, by the Horse Journal, a top industry award for excellence and are sold by BioLargo’s wholly owned subsidiary, Odor-No-More, Inc. (www.OdorNoMore.com). In early 2011, the company signed an exclusive license agreement for use in pet products with industry leader Central Garden and Pet.

Safe Harbor Statement

The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo’s current and future filings with the Securities and Exchange Commission, including those set forth in the BioLargo’s Annual Report on Form 10-K for the year ended December 31, 2010.

Mr.   Johnson’s history and experience in the medical products field is extensive.   In 1991, he began his career as a Market Specialist and Sales Manager with Fortune 100 medical product firm Merck & Co, Inc.   In 1995, Tim began work for a major Swiss medical device manufacturer, Medela, Inc., as their International Sales Manager.   In 2002 he co-founded a medical equipment manufacturer focused on negative pressure advanced wound care therapeutic devices, Blue Sky Medical Group.   He organized and supervised multiple departments, including sales, clinical support, operations and distributors.   He developed multiple products and was responsible for acquiring components used in the company’s devices.   His work and the company’s commerical success led to a sale of the business to Smith & Nephew in 2007.   After selling his device company, he founded a consulting company focusing on assisting medical device companies in sales and marketing, business development, clinical education, product design, research and development, and operations management.   In 2008 he was part of the founders group and worked with Hygeia II Medical Group, Inc.   as VP of Integration, International/Regional Sales Manager, and Special Liaison to the Board of Directors and consultant selling medical products into acute care, government, public health and retail sectors of the market.

“Tim brings to BioLargo a wealth of practical experience in developing clinical products and selling into the medical industry.   Our BioLargo Technology was first discovered by our Inventor and CTO Kenneth Reay Code in his successful personal journey to help keep his father safe from nosocomial infections, which are prevalent in extended care or nursing homes.   Since then we have advanced the science, patents and proofs of claims to the point where we are able to develop specific products that solve unmet needs in the marketplace.   Tim will develop relationships with supply-chain partners within the medical industry to take advantage of the significant commercial opportunities that exist for our non-toxic, non-staining version of iodine based products.   Tim is a proven winner and we are glad he has joined us in this important work,” stated BioLargo President and CEO, Dennis P.   Calvert.

About BioLargo, Inc.

BioLargo’s business strategy is to harness and deliver Nature’s Best Solution™ — free-iodine — in a safe, efficient, environmentally sensitive and cost-effective manner.   BioLargo’s proprietary technology works by combining micro-nutrient salts with liquid from any source to deliver free-iodine on demand, in controlled dosages, in order to balance efficacy of performance with concerns about toxicity.   BioLargo’s technology has potential commercial applications within global industries, including but not limited to oil and gas, animal health, beach and soil environmental uses, consumer products, agriculture, food processing, medical, and water.   It features solutions for odor & moisture control, disinfection and contaminated water treatment.   The company’s website is www.BioLargo.com.   In 2010, Odor-No-More was awarded two Editor’s Choice Awards, including a “Product of the Year” award, by the Horse Journal, a top industry award for excellence and are sold by BioLargo’s wholly owned subsidiary, Odor-No-More, Inc.   (www.OdorNoMore.com).   In early 2011, the company signed an exclusive license agreement for use in pet products with industry leader Central Garden and Pet.

Safe Harbor Statement

The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo’s current and future filings with the Securities and Exchange Commission, including those set forth in the BioLargo’s Annual Report on Form 10-K for the year ended December 31, 2010.

Mr. Roberts spent 14 years as a partner and Director of Marketing at the investment management firm First Quadrant LP prior to his retirement in 2011. First Quadrant is respected globally as an innovative leader and investor in global macro and asset allocation strategies. The firm has been the recipient of four prestigious Graham and Dodd Awards for excellence in investment research during its twenty-year history and continues its long held focus on high level research. During his tenure at First Quadrant, Mr. Roberts served a term as a member of the firm’s governing board responsible for oversight of business operations, compensation, strategy, and public relations. Prior to his involvement with First Quadrant, Mr. Roberts served in a similar capacity as Marketing Director for Provident Capital Management in Philadelphia (1995 to 1997), and co-founded Akamai International, a boutique investment management firm offering institutional investors international equity strategies. He has presented at numerous industry conferences around the world and invited to participate on Institutional Investor’s Advisory Board. From 1987 through 1992, Mr. Roberts worked in the capital markets department for Bankers Trust Company and other regional banks advising multinational corporations on currency risk management strategies. Prior to entering the financial services industry Mr. Roberts worked in oil and gas exploration and consulted on the environmental impact resulting from the development of the Central Arizona Project (the canal that brought water from the Colorado River to both Phoenix and Tucson AZ). Mr. Roberts received a MBA in Finance from the University of Notre Dame in 1986, and a BS in Agriculture and Watershed Hydrology from the University of Arizona in 1982. Mr. Roberts holds a series 3 securities license.

“Rick brings a wealth of practical capital market experience and business contacts to assist in our efforts to secure capital, increase market awareness and exploit our substantial commercial opportunities,” stated BioLargo President and CEO, Dennis P. Calvert.

About BioLargo, Inc.

BioLargo’s business strategy is to harness and deliver Nature’s Best Solution™ — free-iodine — in a safe, efficient, environmentally sensitive and cost-effective manner. BioLargo’s proprietary technology works by combining micro-nutrient salts with liquid from any source to deliver free-iodine on demand, in controlled dosages, in order to balance efficacy of performance with concerns about toxicity. BioLargo’s technology has potential commercial applications within global industries, including but not limited to oil and gas, animal health, beach and soil environmental uses, consumer products, agriculture, food processing, medical, and water. It features solutions for odor & moisture control, disinfection and contaminated water treatment. The company’s website is www.BioLargo.com. In 2010, Odor-No-More was awarded two Editor’s Choice Awards, including a “Product of the Year” award, by the Horse Journal, a top industry award for excellence and are sold by BioLargo’s wholly owned subsidiary, Odor-No-More, Inc. (www.OdorNoMore.com). In early 2011, the company signed an exclusive license agreement for use in pet products with industry leader Central Garden and Pet.

Safe Harbor Statement

The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo’s current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo’s Annual Report on Form 10-K for the year ended December 31, 2010.

“Since winning the Horse Journal “Product of the Year” award last fall, we have enjoyed a surge in brand awareness and extensive customer feedback,” stated Joseph Provenzano, President of BioLargo’s wholly owned operating subsidiary, Odor-No-More, Inc. “As a result, many customers have asked us to produce a smaller sized convenient package. The new packaging will be available for sale to our distributors in July.”

Since executing a license and distribution agreement with Central Garden and Pet in March of this year, the company turned its focus to building additional sales resources within the equine industry. The company announced it has recently executed agreements with four experienced manufacturer’s sales representatives who will focus on specific regions to interact with and provide service to existing and new distributors, retailers and end users to drive market sell-through. “Our new sales representatives have successful track records and have established long standing relationships with distributors and retailers. They will help us cover about 75% of the United States, and provide invaluable in-person interaction with our customers and product retailers,” stated Provenzano. In addition, the company announced the signing of Veterinary Services, Inc. (www.vsi.cc) as a product distributor. VSI supplies products from six locations to over 3,000 customers across the Western United States in the beef, dairy, and poultry business, as well as feed supply and pet stores.

About BioLargo, Inc.

BioLargo’s business strategy is to harness and deliver Nature’s Best Solution™ — free-iodine — in a safe, efficient, environmentally sensitive and cost-effective manner. BioLargo’s proprietary technology works by combining micro-nutrient salts with liquid from any source to deliver free-iodine on demand, in controlled dosages, in order to balance efficacy of performance with concerns about toxicity. BioLargo’s technology has potential commercial applications within global industries, including but not limited to oil and gas, animal health, beach and soil environmental uses, consumer products, agriculture, food processing, medical, and water. It features solutions for odor & moisture control, disinfection and contaminated water treatment. BioLargo’s strategic partner Ioteq IP Pty Ltd. was named a “Top 50 Water Company for the 21st Century” by The Artemis Project™; BioLargo markets Ioteq’s iodine based water disinfection technology, the Isan system. The company’s website is www.BioLargo.com. In 2010, Odor-No-More was awarded two Editor’s Choice Awards, including a “Product of the Year” award, by the Horse Journal, a top industry award for excellence and are sold by BioLargo’s wholly owned subsidiary, Odor-No-More, Inc. (www.OdorNoMore.com).

Safe Harbor Statement

The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, BioLargo’s filings and future filings with the Securities and Exchange Commission, including those set forth in the BioLargo’s Annual Report on Form 10-K for the year ended December 31, 2010.

BioLargo Contacts
Dennis P. Calvert
President
949-643-9540

Howard Isaacs
Investor Relations
562-987-4939
Email Contact